Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability

A technology of non-small cell lung cancer and its composition, which is applied in the field of medicine, can solve the problems of organ bleeding and unfavorable patient prognosis, achieve the effects of relieving TCM symptoms, good drug safety, and improving blood hypercoagulability

Inactive Publication Date: 2015-11-18
JINAN BANGWEN MEDICAL TECH
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Lung cancer patients are often combined with blood hypercoagulability, which is an unbalanced coagulation-anticoagulation-fibrosis system. If not intervened in time, deep vein thrombosis, pulmonary embolism, cerebrovascular accident, disseminated intravascular coagulation and visceral coagulation may occur. Severe complications such as bleeding are not conducive to the prognosis of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability
  • Traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A Chinese medicinal composition for treating hypercoagulable state of non-small cell lung cancer, the weight ratio of each raw material is as follows:

[0027] Astragalus 12g, Eshen 12g, Atractylodes 12g, Salvia 12g, Saffron 12g, Leech 12g, Citrus aurantium 10g, Tangerine peel 10g, Pinellia 10g, Sour plum 10g, Angelica 12g, Black blood vine 12g, Licorice 6g.

Embodiment 2

[0029] A Chinese medicinal composition for treating hypercoagulable state of non-small cell lung cancer, the weight ratio of each raw material is as follows:

[0030] Astragalus 10g, Eshen 10g, Atractylodes macrocephala 10g, Salvia 10g, Saffron 10g, Leech 10g, Citrus aurantium 8g, Tangerine peel 8g, Pinellia 8g, Sour plum 8g, Angelica 10g, Black blood vine 10g, Licorice 5g.

Embodiment 3

[0032] A Chinese medicinal composition for treating hypercoagulable state of non-small cell lung cancer, the weight ratio of each raw material is as follows:

[0033] Astragalus 14g, Eshen 14g, Atractylodes 14g, Salvia 14g, Saffron 14g, Leech 14g, Citrus aurantium 12g, Tangerine Peel 12g, Pinellia 12g, Sour Plum 12g, Angelica 14g, Black Blood Vine 14g, Licorice 7g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability. The traditional Chinese medicine is composed of, by weight, 8-16 parts of milkvetch roots, 8-16 parts of roots of woodland beakchervil, 8-16 parts of rhizoma atractylodis macrocephalae, 8-16 parts of salviae miltiorrhizae, 8-16 parts of saffron, 8-16 parts of hirudo, 6-14 parts of fructus aurantii, 6-14 parts of pericarpium citri reticulatae, 6-14 parts of pinellia ternate, 6-14 parts of twigs and leaves of Tibet lyonia, 8-16 parts of angelica sinensis, 8-16 parts of macrocarpa nucuma and 4-8 parts of radix glycyrrhizae. The traditional Chinese medicine composition for treating the non-small-cell lung cancer hypercoagulability can improve the hypercoagulable state of patients with advanced NSCLC and relieve symptoms of traditional Chinese medicine obviously. Obvious changes of blood routine, liver and kidney functions and electrocardiograms do not exist, and the safety of medication is good.

Description

Technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to a traditional Chinese medicine composition for treating the hypercoagulable state of non-small cell lung cancer. Background technique [0002] Lung cancer (LC) is the most common malignant tumor in the clinic, and the mortality rate ranks first among all malignant tumors. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Lung cancer patients often have blood hypercoagulability, which is an imbalance of the coagulation-anticoagulation-fiber volume system. If not intervened in time, deep vein thrombosis, pulmonary embolism, cerebrovascular accident, diffuse intravascular coagulation and organs can occur Serious complications such as bleeding are not conducive to the prognosis of patients. [0003] Therefore, actively preventing hypercoagulability is a problem that cannot be ignored in the treatment of lung cancer. Summary of the invention [0004] Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P35/00
Inventor 孙睿陈冬梅
Owner JINAN BANGWEN MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products